“…Ellmore and Quattlebaum (1997) described three cases of women with complicated depressive illnesses who responded to fluoxetine, paroxetine, and methylphidate hydrochloride with increased sexual desire, arousal, or activity. Other drugs cited in the literature and thought to induce a hypersexual state include levodopa (Harvey, 1988), carbamapazine (Myers & Carrera, 1989), fluvoxamine (Myers & Carrera, 1989), fluoxetine (Smith & Levitte, 1993), moclobemide (Lauerma, 1995), clomipramine (McLean, Forsythe, & Kapkin, 1982) and trazadone (Sullivan, 1988). The hypersexual states described in the above reports differ from PSAS because they include heightened desire or libido in addition to increased physical arousal, whereas the defining symptom of PSAS is that it is limitated to heightened physical arousal only (Leiblum & Nathan, 2001).…”